Cargando…

Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial

Stunting is reportedly associated with low circulating levels of essential amino acids (EAAs). This study examined the effect of a macronutrient- and micronutrient-fortified complementary food supplement (KOKO Plus) on specific plasma EAA levels and stunting in infants aged 6–18 months. In a single-...

Descripción completa

Detalles Bibliográficos
Autores principales: Furuta, Chie, Sato, Wataru, Murakami, Hitoshi, Suri, Devika J., Otoo, Gloria E., Tano-Debrah, Kwaku, Ghosh, Shibani A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514778/
https://www.ncbi.nlm.nih.gov/pubmed/34660654
http://dx.doi.org/10.3389/fnut.2021.606002
_version_ 1784583468898844672
author Furuta, Chie
Sato, Wataru
Murakami, Hitoshi
Suri, Devika J.
Otoo, Gloria E.
Tano-Debrah, Kwaku
Ghosh, Shibani A.
author_facet Furuta, Chie
Sato, Wataru
Murakami, Hitoshi
Suri, Devika J.
Otoo, Gloria E.
Tano-Debrah, Kwaku
Ghosh, Shibani A.
author_sort Furuta, Chie
collection PubMed
description Stunting is reportedly associated with low circulating levels of essential amino acids (EAAs). This study examined the effect of a macronutrient- and micronutrient-fortified complementary food supplement (KOKO Plus) on specific plasma EAA levels and stunting in infants aged 6–18 months. In a single-blind cluster-randomized controlled trial conducted in Ghana, infants were enrolled at 6 months and followed until 18 months. Thirty-eight communities were randomly assigned to receive KOKO Plus (KP, fourteen communities, n = 321), multiple-micronutrient powder (MN, thirteen communities, n = 327), or only nutritional education as control group (NE, eleven communities, n = 318), and all groups received nutrition education. Plasma amino acids (AAs) were measured at 6, 12, and 18 months (end point). Mixed-effects models were used to assess the effect of the intervention on plasma AAs, and the relationship between plasma branched-chain AAs (BCAAs) and the risk of stunting was assessed. At the end point, total BCAA concentrations (±standard error) significantly exceeded baseline in the KP (284.2 ± 4.3 μM) and NE (289.1 ± 4.4 μM) groups but not the MN group (264.4 ± 4.1 μM). After adjustment for compliance at 200 sachets, plasma BCAAs exceeded in the KP group (284.5 ± 4.2 μM) compared to the MN group (264.6 ± 4 μM). Plasma BCAAs were positively correlated with changes in length-for-age Z-score from baseline (R = 0.327, p = 0.048). In conclusion, the plasma BCAA concentrations of infants that received KP and the NE group was significantly higher compared to the MN group but there were no differences between the KP and NE group at end point. Improved plasma BCAAs may be due to improved nutrient intake by infants exposed to KP or NE. Low BCAAs were associated with stunting, replicating the previous finding. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03181178?term=NCT03181178&draw=2&rank=1, identifier: NCT03181178.
format Online
Article
Text
id pubmed-8514778
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85147782021-10-15 Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial Furuta, Chie Sato, Wataru Murakami, Hitoshi Suri, Devika J. Otoo, Gloria E. Tano-Debrah, Kwaku Ghosh, Shibani A. Front Nutr Nutrition Stunting is reportedly associated with low circulating levels of essential amino acids (EAAs). This study examined the effect of a macronutrient- and micronutrient-fortified complementary food supplement (KOKO Plus) on specific plasma EAA levels and stunting in infants aged 6–18 months. In a single-blind cluster-randomized controlled trial conducted in Ghana, infants were enrolled at 6 months and followed until 18 months. Thirty-eight communities were randomly assigned to receive KOKO Plus (KP, fourteen communities, n = 321), multiple-micronutrient powder (MN, thirteen communities, n = 327), or only nutritional education as control group (NE, eleven communities, n = 318), and all groups received nutrition education. Plasma amino acids (AAs) were measured at 6, 12, and 18 months (end point). Mixed-effects models were used to assess the effect of the intervention on plasma AAs, and the relationship between plasma branched-chain AAs (BCAAs) and the risk of stunting was assessed. At the end point, total BCAA concentrations (±standard error) significantly exceeded baseline in the KP (284.2 ± 4.3 μM) and NE (289.1 ± 4.4 μM) groups but not the MN group (264.4 ± 4.1 μM). After adjustment for compliance at 200 sachets, plasma BCAAs exceeded in the KP group (284.5 ± 4.2 μM) compared to the MN group (264.6 ± 4 μM). Plasma BCAAs were positively correlated with changes in length-for-age Z-score from baseline (R = 0.327, p = 0.048). In conclusion, the plasma BCAA concentrations of infants that received KP and the NE group was significantly higher compared to the MN group but there were no differences between the KP and NE group at end point. Improved plasma BCAAs may be due to improved nutrient intake by infants exposed to KP or NE. Low BCAAs were associated with stunting, replicating the previous finding. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03181178?term=NCT03181178&draw=2&rank=1, identifier: NCT03181178. Frontiers Media S.A. 2021-09-30 /pmc/articles/PMC8514778/ /pubmed/34660654 http://dx.doi.org/10.3389/fnut.2021.606002 Text en Copyright © 2021 Furuta, Sato, Murakami, Suri, Otoo, Tano-Debrah and Ghosh. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Furuta, Chie
Sato, Wataru
Murakami, Hitoshi
Suri, Devika J.
Otoo, Gloria E.
Tano-Debrah, Kwaku
Ghosh, Shibani A.
Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial
title Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial
title_full Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial
title_fullStr Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial
title_full_unstemmed Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial
title_short Changes of Plasma Amino Acid Profiles in Infants With a Nutrient-Fortified Complementary Food Supplement: Evidence From a 12-Month Single-Blind Cluster-Randomized Controlled Trial
title_sort changes of plasma amino acid profiles in infants with a nutrient-fortified complementary food supplement: evidence from a 12-month single-blind cluster-randomized controlled trial
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8514778/
https://www.ncbi.nlm.nih.gov/pubmed/34660654
http://dx.doi.org/10.3389/fnut.2021.606002
work_keys_str_mv AT furutachie changesofplasmaaminoacidprofilesininfantswithanutrientfortifiedcomplementaryfoodsupplementevidencefroma12monthsingleblindclusterrandomizedcontrolledtrial
AT satowataru changesofplasmaaminoacidprofilesininfantswithanutrientfortifiedcomplementaryfoodsupplementevidencefroma12monthsingleblindclusterrandomizedcontrolledtrial
AT murakamihitoshi changesofplasmaaminoacidprofilesininfantswithanutrientfortifiedcomplementaryfoodsupplementevidencefroma12monthsingleblindclusterrandomizedcontrolledtrial
AT suridevikaj changesofplasmaaminoacidprofilesininfantswithanutrientfortifiedcomplementaryfoodsupplementevidencefroma12monthsingleblindclusterrandomizedcontrolledtrial
AT otoogloriae changesofplasmaaminoacidprofilesininfantswithanutrientfortifiedcomplementaryfoodsupplementevidencefroma12monthsingleblindclusterrandomizedcontrolledtrial
AT tanodebrahkwaku changesofplasmaaminoacidprofilesininfantswithanutrientfortifiedcomplementaryfoodsupplementevidencefroma12monthsingleblindclusterrandomizedcontrolledtrial
AT ghoshshibania changesofplasmaaminoacidprofilesininfantswithanutrientfortifiedcomplementaryfoodsupplementevidencefroma12monthsingleblindclusterrandomizedcontrolledtrial